Merganser Biotech
Newtown Square
About Merganser Biotech
Merganser Biotech is a research company that is engaged in the development and licensing of medicines for the treatment of hematological and iron overload diseases that include beta thalassemia and hemochromatosis. The company develops hepcidin mimetic peptides to control iron metabolism and ineffective erythropoiesis. the company was founded 2011 and is based in Newtown Square, Pennsylvania.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $28.0M
- Last round: Series Unknown (Dec 2016)
- Website: merganserbiotech.com
- Phone: (610) 724-9140
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/merganser-biotech-1860905 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.